Raymond James & Associates Schrodinger, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Schrodinger, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 14,202 shares of SDGR stock, worth $294,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,202
Previous 18,829
24.57%
Holding current value
$294,123
Previous $364,000
27.75%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SDGR
# of Institutions
246Shares Held
67.3MCall Options Held
677KPut Options Held
228K-
Black Rock Inc. New York, NY8.52MShares$176 Million0.0% of portfolio
-
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$145 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$136 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.8MShares$99.4 Million2.71% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$90.2 Million0.02% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.28B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...